Company news
Stenocare A/s (OMXCOP:STENO) news
Every Stenocare A/s press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
STENOCARE reports first-half results with continued momentum: Q2 sales rise 33% over Q1 with fifth consecutive EBITDA-positive quarter
August 20, 2026
STENOCARE completes integration of CannGros ApS
July 3, 2026
Notice to Annual General Meeting in STENOCARE A/S
April 7, 2026
STENOCARE A/S publishes Annual Report 2025
March 26, 2026
Interim report fourth quarter and Financial Statement Release 2025
February 26, 2026
STENOCARE A/S positions for First-Mover Advantage in France With Strategic Partnership, Product Filing, and National Distribution Partner...
February 11, 2026
Stenocare Kicks Off Strategic Partnership with WEECO to Launch New Astrum Oil Product in Germany
January 27, 2026
Stenocare acquires Canngros
November 21, 2025
STENOCARE A/S acquires CannGros ApS and add DKK 4-6 million in annual revenue and supports 2026 break even goal
November 17, 2025
Communiqué from the Annual General Meeting of STENOCARE
May 15, 2025
Medical Cannabis Made Permanent in Denmark: Major Milestone for Patients and STENOCARE
May 2, 2025
STENOCARE ASTRUM 10-10 Oil Product Approved for Reimbursement in Germany
April 3, 2025
STENOCARE Begins Sales of New CBD100 Oil Product in Denmark
March 31, 2025
STENOCARE A/S publishes Annual Report 2024
March 27, 2025
Q4 and Annual Financial Statement Release 2024
February 27, 2025
STENOCARE - The innovative ASTRUM 10-10 product is now available for Australian patients
February 14, 2025
STENOCARE A/S Embarks on Strategic Transformation with HQ Relocation and Cultivation Facility Exit
January 29, 2025